| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |